학술논문
Data-driven analysis of a validated risk score for ovarian cancer identifies clinically distinct patterns during follow-up and treatment
Document Type
article
Author
Source
Communications Medicine, Vol 2, Iss 1, Pp 1-13 (2022)
Subject
Language
English
ISSN
2730-664X
Abstract
Enroth et al. validate their previously developed 11-biomarker plasma protein-based risk-score for distinguishing benign vs. malignant ovarian tumors. The risk score is found to be informative of treatment outcome and predictive of 5-year survival.